<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/uthr" ></link>
<id>urn:uuid:dfb6340f-6ffe-dc84-0c9d-a212db4ec54e</id>
<updated>2026-10-08T04:48:20-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $117.76 on 10/6, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6479101" ></link>
<id>urn:uuid:a0f025ee-aaf6-2cca-444e-e9712341718b</id>
<updated>2026-10-07T16:35:13-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $541.70. Mkt Cap:23.2B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $117.76 on 10/5, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6478606" ></link>
<id>urn:uuid:c357fcd3-d6a2-0a8a-a5de-130727e2f465</id>
<updated>2026-10-06T16:32:13-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $541.70. Mkt Cap:23.2B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $117.76 on 10/2, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6477789" ></link>
<id>urn:uuid:3dccce5c-b0f9-e58a-549c-d4ad292c0eab</id>
<updated>2026-10-05T16:53:14-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $541.70. Mkt Cap:23.2B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>UTHR: ROTHBLATT MARTINE A (CEO,DIR) Exercised 9,500 Options (OE) of UNITED THERAPEUTICS CORP for $117.76 on 10/1, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6476349" ></link>
<id>urn:uuid:58d03916-2705-1548-404c-cad6eaae2052</id>
<updated>2026-10-02T16:31:58-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $541.70. Mkt Cap:23.2B. 10D Vol: 1.1mm]]></summary>
</entry>
<entry>
<title>UTHR: MAHON PAUL A (VP,GC) Exercised 8,300 Options (OB) of UNITED THERAPEUTICS CORP for $146.03 on 10/1, and Kept Them All</title>
<link href="http://www.insiderinsights.com/company/uthr/united-therapeutics-corp/id-6475460" ></link>
<id>urn:uuid:c9804930-64d2-742c-8d14-c372e2ab4f99</id>
<updated>2026-10-01T17:30:11-04:00</updated>
<summary type="html" ><![CDATA[UNITED THERAPEUTICS CORP (UTHR). Recent Price: $541.70. Mkt Cap:23.2B. 10D Vol: 1.1mm]]></summary>
</entry>
</feed>